Reducing and Removing Hyaluronic Acid Filler With Hyaluronidase

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

EARLY_PHASE1

Total Enrollment

5 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to find how much hyaluronidase should be used when receiving injections of fillers.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Clinical Investigation to Assess Safety and Performance of Dermal Filler of Hyaluronic Acid

NCT05450380

Skin Folds Wrinkle

COMPLETED NA

Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue

NCT02868749

Atrophy

COMPLETED NA

Evaluation of the Long Term Efficacy and Tolerability of ART FILLER® Volume and Lips

NCT05456971

Aging

COMPLETED NA

Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds

NCT00429520

Nasolabial Folds

COMPLETED PHASE4

Histological and Microbiological Evaluation of Late Occurring Nodules With Hyaluronic Acid Dermal Fillers

NCT03425721

Dermal Nodule

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Drug Safety

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dose of Hyaluronidase

Group Type EXPERIMENTAL

Hyaluronidase

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hyaluronidase

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 and over
* The subjects are in good health
* The subject has the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator

Exclusion Criteria

* Under 18 years of age
* Pregnancy or Lactation
* Subjects who are unable to understand the protocol or to give informed consent
* Subjects with mental illness
* Recent Accutane use in the past 6 months
* Subjects prone to hypertrophic and keloidal scarring
* Subjects with tattoos and/or scars on upper medial arms (the treatment area)
* Subjects with known hypersensitivity to hyaluronic acid

Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes